Dr. Erika Wang's research integrates micro- and nano-engineering, biomaterials, tissue engineering and controlled therapeutic delivery to create programmable platforms for disease modelling, regenerative medicine and precision therapeutics.
Professor Wang completed a PhD in biomedical engineering at the University of Toronto, where she developed engineered tissues and organ-on-chip systems for human disease modelling and preclinical drug testing. She completed postdoctoral training at the Koch Institute for Integrative Cancer Research at MIT as a Banting postdoctoral fellow, working on programmable micro- and nanoscale drug delivery systems for vaccines, tissue regeneration and disease therapeutics.
Professor Wang’s laboratory will develop AI-aided nanomedicine formulation engineering, vascularized and neurovascular tissue models, and implantable or on-demand delivery technologies to connect engineering innovation with translational health applications.
Professor Wang will be starting at uOttawa on August 1st, 2026.